These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8212845

  • 1. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
    O'Hagan DT, Jeffery H, Davis SS.
    Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845
    [Abstract] [Full Text] [Related]

  • 2. Controlled release microparticles for vaccine development.
    O'Hagan DT, Jeffery H, Roberts MJ, McGee JP, Davis SS.
    Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H, Lavelle EC, Coombes AG, Stolnik S, Holland J, Davis SS.
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [Abstract] [Full Text] [Related]

  • 10. Biodegradable microparticles as controlled release antigen delivery systems.
    O'Hagan DT, Rahman D, McGee JP, Jeffery H, Davies MC, Williams P, Davis SS, Challacombe SJ.
    Immunology; 1991 Jun; 73(2):239-42. PubMed ID: 2071168
    [Abstract] [Full Text] [Related]

  • 11. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A, Lavelle EC, Hartshorne M, Davis SS.
    Vaccine; 1999 Jul 16; 17(22):2927-38. PubMed ID: 10438065
    [Abstract] [Full Text] [Related]

  • 12. Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Kavanagh OV, Earley B, Murray M, Foster CJ, Adair BM.
    Vaccine; 2003 Oct 01; 21(27-30):4472-80. PubMed ID: 14505930
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
    Tabata Y, Inoue Y, Ikada Y.
    Vaccine; 1996 Dec 01; 14(17-18):1677-85. PubMed ID: 9032899
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T, Goto S, Foster TP.
    J Pharm Pharmacol; 1995 Jul 01; 47(7):556-60. PubMed ID: 8568620
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination.
    Yeh M, Chiang C.
    J Microencapsul; 2004 Feb 01; 21(1):91-106. PubMed ID: 14718189
    [Abstract] [Full Text] [Related]

  • 19. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D, Gander B, Kündig TM, Johansen P.
    Eur J Pharm Biopharm; 2012 Feb 01; 80(2):274-81. PubMed ID: 22024408
    [Abstract] [Full Text] [Related]

  • 20. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.
    Takahata H, Lavelle EC, Coombes AG, Davis SS.
    J Control Release; 1998 Jan 02; 50(1-3):237-46. PubMed ID: 9685890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.